图片: | |
---|---|
名称: | |
描述: | |
以下是引用海上明月在2010-8-24 12:50:00的发言: 请楼主张主任发表贵单位意见。谢谢! |
谢谢王主任的关注,在回答问题之前让我们共同学习一下有关内容:
Variability in Diagnostic Opinion Among Pathologists
for Single Small Atypical Foci in Prostate Biopsies
(Am J Surg Pathol 2010;00:000–000)
Abstract: Pathologists are increasingly exposed to prostate
biopsies with small atypical foci, requiring differentiation
between adenocarcinoma, atypical small acinar proliferation
suspicious for malignancy, and a benign diagnosis. We studied
the level of agreement for such atypical foci among experts in
urologic pathology and all-round reference pathologists of the
European Randomized Screening study of Prostate Cancer
(ERSPC). For this purpose, we retrieved 20 prostate biopsies
with small (most <1 mm) atypical foci. Hematoxylin and eosinstained
slides, including 10 immunostained slides were digitalized
for virtual microscopy. The lesional area was not marked.
Five experts and 7 ERSPC pathologists examined the cases.
Multirater k statistics was applied to determine agreement and
significant differences between experts and ERSPC pathologists.
The k value of experts (0.39; confidence interval, 0.29-0.49) was
significantly higher than that of ERSPC pathologists (0.21;
confidence interval, 0.14-0.27). Full (100%) agreement was
reached by the 5 experts for 7 of 20 biopsies. Experts and
ERSPC pathologists rendered diagnoses ranging from benign
to adenocarcinoma on the same biopsy in 5 and 9 biopsies,
respectively. Most of these lesions comprised between 2 and 5
atypical glands. The experts diagnosed adenocarcinoma (49%)
more often than the ERSPC pathologists (32%) (P<0.001). As
agreement was particularly poor for foci comprising <6 glands,
we would encourage pathologists to obtain intercollegial consultation
of a specialized pathologist for these lesions before a
carcinoma diagnosis, whereas clinicians may consider to perform
staging biopsies before engaging on deferred or definite therapy.
Key Words: prostate cancer, prostate biopsy, pathology,
diagnostics, interobserver variation, virtual microscopy
前列腺活检组织中单个不典型病灶(上述文献定义为直径小于1mm) 与癌的鉴别是病理诊断的难题。张主任提供的文献已很好的证明此点。即使是训练有素、有丰富经验的专家,对这种病例的诊断一致性不到50%、而普通病理医生诊断的一致性仅30%。
这种情况在教科书中称为不典型小腺泡增生(Atypical small acinar proliferation, ASAP), 与癌的鉴别诊断并不能根据一项指标, 而要综合分析结构(Pattern)、细胞学、生长方式、和IHC标记。可疑腺泡的数量越少、结构与邻近正常腺泡越接近,诊断就越困难。在前列腺活检中ASAP的发生率约为3%,其中45%经泌尿病理专家会诊可明确诊断。如果患者年龄小于75岁,可建议再次活检,大于75岁,可由临床医生和患者讨论是否再活检。
以下是引用xljin8在2010-8-25 12:42:00的发言:
前列腺活检组织中单个不典型病灶(上述文献定义为直径小于1mm) 与癌的鉴别是病理诊断的难题。张主任提供的文献已很好的证明此点。即使是训练有素、有丰富经验的专家,对这种病例的诊断一致性不到50%、而普通病理医生诊断的一致性仅30%。 这种情况在教科书中称为不典型小腺泡增生(Atypical small acinar proliferation, ASAP), 与癌的鉴别诊断并不能根据一项指标, 而要综合分析结构(Pattern)、细胞学、生长方式、和IHC标记。可疑腺泡的数量越少、结构与邻近正常腺泡越接近,诊断就越困难。在前列腺活检中ASAP的发生率约为3%,其中45%经泌尿病理专家会诊可明确诊断。如果患者年龄小于75岁,可建议再次活检,大于75岁,可由临床医生和患者讨论是否再活检。 |
以下是引用doudou20080626在2010-8-23 17:30:00的发言: 学习了,前段时间遇到一例,本人考虑为高分化癌,科主任直接给我否定了。其实它的PSA也是25,P63部分腺体不表达。迷惑的是我们的P504S阴性。 |
P504S这个抗体做出来有时是会使人困惑,这其中有技术方面的原因,也有抗体供应方面的问题。
技术上的问题主要可能有固定是否及时的因素,因为P504s是一种参与脂肪酸支链及其之间产物代谢的酶,如果固定不及时或固定不良,容易导致该酶降解。技术上的因素还有抗原修复的步骤没掌握好火候,这个平常要拿阳性对照片去试,看什么样的修复温度和修复时间比较合适。还有一些IHC操作细节问题。
抗体供应上的问题主要是这个抗体使用的相对较少,所以在购买前供应商那里可能储藏的时间较长,其效价降低,特别是即用型抗体,买来后很少用而久存,也会降低效价。这时,解决的办法就是在即用型抗体中,加几滴未稀释的原始一抗,以提供有效抗体效价,说不定使用起来效果会好些。
仅供参考。